Navigation Links
Infants must be put to sleep in separate beds to prevent SIDS

SIDS is the sudden and unexplained death of an infant. It is the leading cause of death among infants who are 1 month to 1 year old. SIDS should be diagnosed only when all other possible causes of death have been ruled out by a detailed evaluation of the medical history//.

There is no specific symptom to diagnose the condition. A new study conducted shows that the condition can be prevented by putting babies to sleep in their own cribs instead of in their parents' beds. It is indeed a coincidence that the news has been released just during SIDS awareness month (October).

The research further points out that babies who sleep in an adult bed face a 40 % more risk of suffocation than their counterparts who sleep in standard cribs. The condition is also found to be more common among African-American infants than in babies of other races. The fact that these children are more likely to be put to sleep in adult beds or on surfaces other than cribs, such as sofas accounts for the increased incidence.

A number of factors have been identified for sleeping with kids including the inability to afford a safe crib. In addition bed sharing is supposed to promote breastfeeding and closeness.

A number of recommendations have been suggested by the research committee to reduce the risk of SIDS in infants. The first one that advocates putting babies to sleep in a separate but proximate sleeping atmosphere such as a crib, bassinet or cradle that is located in the parent’s bedroom. This arrangement will pave way for more convenient breastfeeding and contact. In addition practices such as infants sharing beds with other children, sleeping with adults on a couch or armchair should never be encouraged.

Emphasis is also given to placing babies on their backs rather than on their stomach and sides. Moreover, babies should be put to sleep in a room that isn’t overly hot on a firm crib mattress, covered by a sheet. The use of soft, cushy bedd
'"/>




Page: 1 2

Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Benefits of Nitric Oxide in the Treatment of Premature Infants
3. New Technique to Study Infants Brain.
4. Limiting Infants Exposure To Smoke At Home
5. fMRI Offers Insight Into An Infants Brain
6. Drug Used To Improve Lung Function In Infants Could Slow Down Motor Coordination
7. Infants going to day-care may have lower risk of leukemia
8. Infants at lower risk from digestive disease if introduced to cereal early
9. New Blood Test To Detect Iron Level In Infants
10. Plump Infants Getting Obese Later In Life In More Cases
11. Effect of Maternal Diet on Colic Among Breastfed Infants

Post Your Comments:
(Date:11/30/2009)...O A large proportion of patients who undergo abdo...dicated and unnecessary additional image acquisiti...re, according to a study presented today at the an...America (RSNA). , "It is the responsibility of a...ensure that the dosage is as low as reasonably ach...
(Date:11/29/2009)..., ATLANTA, Nov. 29 The followin...livest Securities Research, Inc. ,, Intellivest...stered investment advisor, has published a Report ... in the pharmaceutical, biotechnology and medical ...heir clients manage, process and submit medical im...
(Date:11/29/2009)...ng someone get blamed for something leads to more ... , SUNDAY, Nov. 29 (HealthDay News) -- The bl... even when the target is innocent. , Researcher... else for a problem, even if it,s an unfair accusa...g others, too. , "When we see others protectin...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welcome to...solution for the clinical routine from Siemens H...Communications System (PACS) from Siemens where ... syngo .plaza is poised to change the way mul...ling this innovation at the 95th Scientific Asse...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall...any"), a supplier of precision technology products...n annual meeting of the Company,s shareholders has...ime and location of the meeting will be announced ...ny received a requisition notice from Stephen Bers...
Breaking Medicine News(10 mins):Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2
...fering from Insomnia , , LOS ANGELES, March 31 F...ng and negative impact than a lost night,s sleep. ...nd the endless array of other daily responsibiliti...nfortunately, many women are doing just that, and ...
...vides Extensive Services & Support , , SAN FR...xperienced provider of in home support and recover... its San Francisco location. Interim HomeStyle Se...r from illness. , , The San Francisco location w...
... top, industry employers across North Carolina , ...h 31, 2009 -- BioSpace , the leading resource for...e seventh edition of the Bio NC Hotbed Campaign ...Research Triangle Park and other areas of North Ca...
...FACP is in the private practice of internal medici... the best doctors in New Jersey by New Jersey Mont...;Top Doctor" accolade for the third consecuti... year in the November, 2008 issue of New Jersey Mo...
...laxoSmithKline plc (NYSE: GSK ) has entered into..., Nasdaq: SHPGY ) for Vy v a n s e(R) , to...lt Attention Deficit Hyperactivity Disorder (ADHD)...in discovering and developing medicines to treat p...
...nuts sold in at least 31 states , , MONDAY...Administration officials said Monday night that th...on that could involve 1 million pounds of pistachi... said. , "We are not dealing with an outbreak here...
Other Medicine News:Health News:Tired of Sleepless Nights? 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:BioSpace Launches the 2009 Bio NC™ Hotbed Campaign 2Health News:Dr Howard Holtz Named New Jersey Top Doctor for Third Consecutive Year 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 3Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 4Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 5Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 6Health News:FDA Investigating Salmonella-Tainted Pistachios 2
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-Fir...hat Dr. Michael J. McKelvey, the Company,s Preside...tive Vice President and CFO, are scheduled to pres...onference at 1:30 PM EST on December 1, 2009 in Ne...y access the presentation by visiting the Company,...
(Date:11/25/2009)... , BRIDGEWATER, N.J., Nov. 25 ...® (etravirine) tablets, a non-nucleoside reve...the only NNRTI specifically indicated for use in t...irologic failure with HIV-1 strains resistant to a...e traditional approval is based on 48-week data fr...
(Date:11/25/2009)... , RANCHO CORDOVA, Calif., Nov. 25 /PRNewswir... of American Pacific Corporation (Nasdaq: APFC ) ... Responsibility and Sustainability Award at the An...the California Manufacturers and Technology Associ...tion (IEA) and the Chemical Industry Council of Ca...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 1Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 1Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 3Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 4FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 1FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 2FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 3
...26 The Blumenthal,Cancer Center at Carolinas Medi...he Moffitt Cancer Center in a study that could lea...of cancer. CMC is the first hospital system,outsid... Over the next five years, CMC will enroll more t...e collecting tissue samples, medical histories,and...
...26 Pharmacopeia,(Nasdaq: PCOP ), an innovator in...cule therapeutics, today announced the completion ... 2a clinical study of PS433540 (DARA),the company,...f the Phase,2a randomized, double-blind, placebo-c... efficacy and safety of 200 and 500 mg of PS433540...
Other Medicine Technology:CMC, Moffitt Partner to Study Cancer 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4
ABL800 FLEX Blood Gas Analyzer
Flatbed Agitator PFS84
Flatbed Agitator PFS42
...telet agitators offer a wide range of storage capa... storage platform to agitate smoothly, eliminating...ueak. Sturdy, one-piece perforated drawers with no...ation for your platelets., ,i.Series platelet ...
Medicine Products: